Protagenic Therapeutics, Inc. (PTIX) Financial Statements (2024 and earlier)

Company Profile

Business Address 149 FIFTH AVENUE
NEW YORK, NY 10010
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,97910,3716717993621,685
Cash and cash equivalents215541671799362400
Short-term investments7,7649,830   1,286
Prepaid expense  208438395
Other undisclosed current assets 57689  250 
Total current assets:8,03611,0608798426961,780
Noncurrent Assets
Property, plant and equipment2  011
Total noncurrent assets:2  011
TOTAL ASSETS:8,03711,0608798426971,781
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:670500572865232136
Accrued liabilities  1421631011
Other undisclosed accounts payable and accrued liabilities 670500430702222125
Debt 151     
Derivative instruments and hedges, liabilities   84332676426
Due to related parties194     
Other undisclosed current liabilities106300    
Total current liabilities:1,1208006551,197908562
Noncurrent Liabilities
Long-term debt and lease obligation  1321,081175  
Long-term debt, excluding current maturities  1321,081175  
Liabilities, other than long-term debt  186    
Due to related parties 186    
Other undisclosed noncurrent liabilities   292105  
Total noncurrent liabilities:  3181,374279  
Total liabilities:1,1201,1182,0291,477908562
Equity
Equity, attributable to parent, including:6,9189,942(1,150)(634)(211)1,219
Common stock021111
Additional paid in capital33,37132,41016,72014,68713,35812,228
Accumulated other comprehensive loss(677)(248)(172)(172)(171)(168)
Accumulated deficit(25,777)(22,222)(17,699)(15,150)(13,399)(10,842)
Other undisclosed equity, attributable to parent   0000
Total equity:6,9189,942(1,150)(634)(211)1,219
TOTAL LIABILITIES AND EQUITY:8,03711,0608798426971,781

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues
(Other Operating Income)
     314
Gross profit:     314
Operating expenses(3,558)(4,140)(2,552)(2,086)(2,314)(2,365)
Other undisclosed operating loss     (3)(14)
Operating loss:(3,558)(4,140)(2,552)(2,086)(2,314)(2,365)
Nonoperating income (expense)2(383)3335(243)106
Investment income, nonoperating18633    
Other nonoperating expense   (246)(13)  
Interest and debt expense(137)(497) (100)  
Other undisclosed income from continuing operations before equity method investments, income taxes    100  
Loss from continuing operations before equity method investments, income taxes:(3,693)(5,020)(2,549)(1,751)(2,558)(2,260)
Other undisclosed income from continuing operations before income taxes137497    
Loss from continuing operations:(3,556)(4,523)(2,549)(1,751)(2,558)(2,260)
Loss before gain (loss) on sale of properties:(4,523)(2,549)(1,751)(2,558)(2,260)
Net loss available to common stockholders, diluted:(3,556)(4,523)(2,549)(1,751)(2,558)(2,260)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(3,556)(4,523)(2,549)(1,751)(2,558)(2,260)
Other comprehensive income (loss)    5(6) 
Comprehensive loss:(3,556)(4,523)(2,549)(1,746)(2,564)(2,260)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(429)(77)1(11)414
Comprehensive loss, net of tax, attributable to parent:(3,984)(4,600)(2,548)(1,758)(2,560)(2,246)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: